SCHEMBL13613774

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1C=NC=N1)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)C(C)C

nearest known ligand 0.59

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	GALR2	O43603	2/20	0.59

▸	GALR1	P47211	2/20	0.59

▸	CALCA	P06881	2/20	0.54

▸	GLP1R	P43220	12/20	0.54

▸	GIPR	P48546	12/20	0.54

▸	NMBR	P28336	2/20	0.53

▸	GRPR	P30550	2/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30429448	0.88	GALR2 (0.62)	GALR2GALR1CALCAGLP1RGIPR
SCHEMBL29454204	0.87	NPY1R (0.61)	CALCAGLP1RGIPR
SCHEMBL30429667	0.86	NMBR (0.60)	GALR2GALR1CALCAGLP1RGIPR
SCHEMBL30429251	0.86	CALCA (0.62)	GALR2GALR1CALCAGLP1R
SCHEMBL13613776	0.85	GALR2 (0.54)	GALR2GALR1CALCAGLP1RGIPR
SCHEMBL13613775	0.85	GALR2 (0.54)	GALR2GALR1CALCAGLP1RGIPR
Galantide SCHEMBL31332196	0.85	IL23R (0.62)	GALR2GALR1GLP1RGIPRNMBR
SCHEMBL29992945	0.84	CALCA (0.59)	GALR2GALR1CALCA
SCHEMBL29973367	0.84	CXCL8 (0.62)	GALR2GALR1GLP1RGIPRNMBR
SCHEMBL31061583	0.84	GALR2 (0.65)	GALR2GALR1GLP1RGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20090275727-A1	Peptide turn mimetics	MIMETICA PTY LIMITED (AU)	2009-11-05	—	—	US	disclosed
US-20090275727-A1	Peptide turn mimetics	MIMETICA PTY LIMITED (AU)	2009-11-05	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20090275727-A1	Peptide turn mimetics	IAPP, GLP1R, VIP	GALR2 1737/4885GALR1 1017/4885CALCA 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.